Want to see AU:BGT full AI Analyst Report?
Bio-Gene Technology Ltd. (BGT) Income Statement
Bio-Gene Technology Ltd. Income Statement
Last quarter (Q4 2026), Bio-Gene Technology Ltd.'s total revenue was $0.00, an increase of 100.00% from the same quarter last year. In Q4, Bio-Gene Technology Ltd.'s net income was $-930.12K. See Bio-Gene Technology Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 18.32K | $ 149.23K | $ 445.73K | |
| $ -42.00K | $ -245.78K | $ -301.45K | $ -164.04K | $ 178.59K | |
| $ 3.36M | $ 2.82M | $ 2.76M | $ 3.46M | $ 3.59M | |
| Depreciation and Amortization | $ 42.00K | $ 41.93K | $ 38.38K | $ 45.30K | $ 43.52K |
| $ -3.36M | $ -2.58M | $ -2.97M | $ -3.14M | $ -2.92M | |
| $ -3.41M | $ -3.07M | $ -3.06M | $ -3.63M | $ -3.41M | |
| $ 606.27K | $ 482.44K | $ 49.10K | $ 86.21K | $ 59.34K | |
| $ -2.80M | $ -2.58M | $ -3.01M | $ -3.10M | $ -2.91M | |
| $ -2.33M | $ -2.58M | $ -2.41M | $ -3.10M | $ -2.91M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.01 | $ -0.01 | $ -0.02 | $ -0.02 |
| Diluted EPS | $ -0.01 | $ -0.01 | $ -0.01 | $ -0.02 | $ -0.02 |
| Weighted Average Shares Outstanding | 309.11M | 211.24M | 185.32M | 167.77M | 153.34M |
| Weighted Average Shares Outstanding (Diluted) | 309.11M | 211.24M | 185.82M | 167.77M | 153.34M |
Currency in AUD
